{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:12:18Z","timestamp":1793416338545,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK118021"],"award-info":[{"award-number":["R01DK118021"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["CTSA-TPP-YR3-D-002"],"award-info":[{"award-number":["CTSA-TPP-YR3-D-002"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00467-024-06395-5","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:02:05Z","timestamp":1718370125000},"page":"3439-3451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The role of fibroblast growth factor 23 in regulation of phosphate balance"],"prefix":"10.1007","volume":"39","author":[{"given":"Raphael","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neije","family":"Mukherjee-Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-0411","authenticated-orcid":false,"given":"Jyothsna","family":"Gattineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"6395_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00424-003-1072-5","volume":"447","author":"H Murer","year":"2004","unstructured":"Murer H, Forster I, Biber J (2004) The sodium phosphate cotransporter family SLC34. Pflugers Arch 447:763\u2013767","journal-title":"Pflugers Arch"},{"key":"6395_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2215\/CJN.06080809","volume":"5","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519\u2013530","journal-title":"Clin J Am Soc Nephrol"},{"key":"6395_CR3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00467-012-2103-2","volume":"27","author":"J Gattineni","year":"2012","unstructured":"Gattineni J, Baum M (2012) Genetic disorders of phosphate regulation. Pediatr Nephrol 27:1477\u20131487","journal-title":"Pediatr Nephrol"},{"key":"6395_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/adc.57.3.217","volume":"57","author":"K Kruse","year":"1982","unstructured":"Kruse K, Kracht U, Gopfert G (1982) Renal threshold phosphate concentration (TmPO4\/GFR). Arch Dis Child 57:217\u2013223","journal-title":"Arch Dis Child"},{"key":"6395_CR5","doi-asserted-by":"publisher","first-page":"14564","DOI":"10.1073\/pnas.95.24.14564","volume":"95","author":"H Hilfiker","year":"1998","unstructured":"Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J (1998) Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci U S A 95:14564\u201314569","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6395_CR6","first-page":"G756","volume":"277","author":"O Hattenhauer","year":"1999","unstructured":"Hattenhauer O, Traebert M, Murer H, Biber J (1999) Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am J Physiol 277:G756\u2013G762","journal-title":"Am J Physiol"},{"key":"6395_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF00658486","volume":"388","author":"G Danisi","year":"1980","unstructured":"Danisi G, Bonjour JP, Straub RW (1980) Regulation of Na-dependent phosphate influx across the mucosal border of duodenum by 1,25-dihydroxycholecalciferol. Pflugers Arch 388:227\u2013232","journal-title":"Pflugers Arch"},{"key":"6395_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00223-020-00686-3","volume":"108","author":"M Peacock","year":"2021","unstructured":"Peacock M (2021) Phosphate metabolism in health and disease. Calcif Tissue Int 108:3\u201315","journal-title":"Calcif Tissue Int"},{"key":"6395_CR9","doi-asserted-by":"publisher","first-page":"F643","DOI":"10.1152\/ajprenal.00228.2007","volume":"293","author":"LV Virkki","year":"2007","unstructured":"Virkki LV, Biber J, Murer H, Forster IC (2007) Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol 293:F643\u2013F654","journal-title":"Am J Physiol Renal Physiol"},{"key":"6395_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Lichtner P, Schnabel D, Hochberg Z, Strom TM (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78:193\u2013201","journal-title":"Am J Hum Genet"},{"key":"6395_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2006","unstructured":"Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, Garabedian M, Sermet I, Fujiwara TM, Morgan K, Tenenhouse HS, Juppner H (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78:179\u2013192","journal-title":"Am J Hum Genet"},{"key":"6395_CR12","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","volume":"95","author":"L Beck","year":"1998","unstructured":"Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 95:5372\u20135377","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6395_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00467-017-3873-3","volume":"34","author":"CA Wagner","year":"2019","unstructured":"Wagner CA, Rubio-Aliaga I, Hernando N (2019) Renal phosphate handling and inherited disorders of phosphate reabsorption: an update. Pediatr Nephrol 34:549\u2013559","journal-title":"Pediatr Nephrol"},{"key":"6395_CR14","doi-asserted-by":"publisher","first-page":"1163442","DOI":"10.3389\/fphar.2023.1163442","volume":"14","author":"ML Jennings","year":"2023","unstructured":"Jennings ML (2023) Role of transporters in regulating mammalian intracellular inorganic phosphate. Front Pharmacol 14:1163442","journal-title":"Front Pharmacol"},{"key":"6395_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"6395_CR16","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98:6500\u20136505","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6395_CR17","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079\u20132086","journal-title":"Kidney Int"},{"key":"6395_CR18","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA, Boot AM, Hogler W, Linglart A, Padidela R, Van\u2019t Hoff W, Mao M, Chen CY, Skrinar A, Kakkis E, San Martin J, Portale AA (2018) Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 378:1987\u20131998","journal-title":"N Engl J Med"},{"key":"6395_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345\u2013348","journal-title":"Nat Genet"},{"key":"6395_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbagen.2008.09.001","volume":"1790","author":"M Asada","year":"2009","unstructured":"Asada M, Shinomiya M, Suzuki M, Honda E, Sugimoto R, Ikekita M, Imamura T (2009) Glycosaminoglycan affinity of the complete fibroblast growth factor family. Biochim Biophys Acta 1790:40\u201348","journal-title":"Biochim Biophys Acta"},{"key":"6395_CR21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.bone.2007.01.017","volume":"40","author":"Y Yoshiko","year":"2007","unstructured":"Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maeda N (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40:1565\u20131573","journal-title":"Bone"},{"key":"6395_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","volume":"31","author":"M Leifheit-Nestler","year":"2016","unstructured":"Leifheit-Nestler M, Grosse Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D (2016) Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Nephrol Dial Transplant 31:1088\u20131099","journal-title":"Nephrol Dial Transplant"},{"key":"6395_CR23","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1210\/jc.2018-00123","volume":"103","author":"F Bienaime","year":"2018","unstructured":"Bienaime F, Ambolet A, Aussilhou B, Brazier F, Fouchard M, Viau A, Barre P, Tissier AM, Correas JM, Paradis V, Terzi F, Friedlander G, Knebelmann B, Joly D, Prie D (2018) Hepatic production of fibroblast growth factor 23 in autosomal dominant polycystic kidney disease. J Clin Endocrinol Metab 103:2319\u20132328","journal-title":"J Clin Endocrinol Metab"},{"key":"6395_CR24","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41598-017-02709-w","volume":"7","author":"ER Smith","year":"2017","unstructured":"Smith ER, Tan SJ, Holt SG, Hewitson TD (2017) FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts. Sci Rep 7:3345","journal-title":"Sci Rep"},{"key":"6395_CR25","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","volume":"102","author":"EL Clinkenbeard","year":"2017","unstructured":"Clinkenbeard EL, Hanudel MR, Stayrook KR, Appaiah HN, Farrow EG, Cass TA, Summers LJ, Ip CS, Hum JM, Thomas JC, Ivan M, Richine BM, Chan RJ, Clemens TL, Schipani E, Sabbagh Y, Xu L, Srour EF, Alvarez MB, Kacena MA, Salusky IB, Ganz T, Nemeth E, White KE (2017) Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow. Haematologica 102:e427\u2013e430","journal-title":"Haematologica"},{"key":"6395_CR26","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.1182\/bloodadvances.2022009524","volume":"7","author":"X Li","year":"2023","unstructured":"Li X, Lozovatsky L, Tommasini SM, Fretz J, Finberg KE (2023) Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia. Blood Adv 7:5156\u20135171","journal-title":"Blood Adv"},{"key":"6395_CR27","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2002) Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143:3179\u20133182","journal-title":"Endocrinology"},{"key":"6395_CR28","doi-asserted-by":"publisher","first-page":"18370","DOI":"10.1074\/jbc.M602469200","volume":"281","author":"K Kato","year":"2006","unstructured":"Kato K, Jeanneau C, Tarp MA, Benet-Pages A, Lorenz-Depiereux B, Bennett EP, Mandel U, Strom TM, Clausen H (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 281:18370\u201318377","journal-title":"J Biol Chem"},{"key":"6395_CR29","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","volume":"111","author":"VS Tagliabracci","year":"2014","unstructured":"Tagliabracci VS, Engel JL, Wiley SE, Xiao J, Gonzalez DJ, Nidumanda AH, Koller A, Nizet V, White KE, Dixon JE (2014) Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc Natl Acad Sci U S A 111:5520\u20135525","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6395_CR30","doi-asserted-by":"publisher","first-page":"28265","DOI":"10.1074\/jbc.M202527200","volume":"277","author":"T Yamashita","year":"2002","unstructured":"Yamashita T, Konishi M, Miyake A, Inui K, Itoh N (2002) Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem 277:28265\u201328270","journal-title":"J Biol Chem"},{"key":"6395_CR31","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1210\/en.2005-0670","volume":"146","author":"X Yu","year":"2005","unstructured":"Yu X, Ibrahimi OA, Goetz R, Zhang F, Davis SI, Garringer HJ, Linhardt RJ, Ornitz DM, Mohammadi M, White KE (2005) Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146:4647\u20134656","journal-title":"Endocrinology"},{"key":"6395_CR32","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120\u20136123","journal-title":"J Biol Chem"},{"key":"6395_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770\u2013774","journal-title":"Nature"},{"key":"6395_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45\u201351","journal-title":"Nature"},{"key":"6395_CR35","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1073\/pnas.0709805104","volume":"104","author":"CD Chen","year":"2007","unstructured":"Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR (2007) Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A 104:19796\u201319801","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6395_CR36","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1016\/j.febslet.2009.09.009","volume":"583","author":"L Bloch","year":"2009","unstructured":"Bloch L, Sineshchekova O, Reichenbach D, Reiss K, Saftig P, Kuro-o M, Kaether C (2009) Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett 583:3221\u20133224","journal-title":"FEBS Lett"},{"key":"6395_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1006\/bbrc.1997.8019","volume":"242","author":"Y Matsumura","year":"1998","unstructured":"Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y (1998) Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242:626\u2013630","journal-title":"Biochem Biophys Res Commun"},{"key":"6395_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0014-5793(98)00127-6","volume":"424","author":"T Shiraki-Iida","year":"1998","unstructured":"Shiraki-Iida T, Aizawa H, Matsumura Y, Sekine S, Iida A, Anazawa H, Nagai R, Kuro-o M, Nabeshima Y (1998) Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett 424:6\u201310","journal-title":"FEBS Lett"},{"key":"6395_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1177\/002215549704500710","volume":"45","author":"SE Hughes","year":"1997","unstructured":"Hughes SE (1997) Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45:1005\u20131019","journal-title":"J Histochem Cytochem"},{"key":"6395_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1568-1637(02)00027-2","volume":"1","author":"Y Nabeshima","year":"2002","unstructured":"Nabeshima Y (2002) Klotho: a fundamental regulator of aging. Ageing Res Rev 1:627\u2013638","journal-title":"Ageing Res Rev"},{"key":"6395_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature25451","volume":"553","author":"G Chen","year":"2018","unstructured":"Chen G, Liu Y, Goetz R, Fu L, Jayaraman S, Hu MC, Moe OW, Liang G, Li X, Mohammadi M (2018) alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature 553:461\u2013466","journal-title":"Nature"},{"key":"6395_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.11.149","volume":"138","author":"X Han","year":"2020","unstructured":"Han X, Cai C, Xiao Z, Quarles LD (2020) FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. J Mol Cell Cardiol 138:66\u201374","journal-title":"J Mol Cell Cardiol"},{"key":"6395_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MNH.0000000000000467","volume":"28","author":"LD Quarles","year":"2019","unstructured":"Quarles LD (2019) Fibroblast growth factor 23 and alpha-Klotho co-dependent and independent functions. Curr Opin Nephrol Hypertens 28:16\u201325","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"6395_CR44","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, Di Marco GS, Kentrup D, Reuter S, Mayer AB, Pavenstadt H, Stypmann J, Kuhn C, Hille S, Frey N, Leifheit-Nestler M, Richter B, Haffner D, Abraham R, Bange J, Sperl B, Ullrich A, Brand M, Wolf M, Faul C (2015) Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 22:1020\u20131032","journal-title":"Cell Metab"},{"key":"6395_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S, Czaja MJ, Bartz R, Abraham R, Di Marco GS, Brand M, Wolf M, Faul C (2016) Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int 90:985\u2013996","journal-title":"Kidney Int"},{"key":"6395_CR46","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/JME-20-0089","volume":"66","author":"S Fukumoto","year":"2021","unstructured":"Fukumoto S (2021) FGF23-related hypophosphatemic rickets\/osteomalacia: diagnosis and new treatment. J Mol Endocrinol 66:R57\u2013R65","journal-title":"J Mol Endocrinol"},{"key":"6395_CR47","doi-asserted-by":"publisher","first-page":"588096","DOI":"10.3389\/fendo.2021.588096","volume":"12","author":"DMA Ratsma","year":"2021","unstructured":"Ratsma DMA, Zillikens MC, van der Eerden BCJ (2021) Upstream regulators of fibroblast growth factor 23. Front Endocrinol (Lausanne) 12:588096","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6395_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00223-023-01092-1","volume":"113","author":"E Clinkenbeard","year":"2023","unstructured":"Clinkenbeard E (2023) Fibroblast growth factor 23 bone regulation and downstream hormonal activity. Calcif Tissue Int 113:4\u201320","journal-title":"Calcif Tissue Int"},{"key":"6395_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00424-022-02668-w","volume":"474","author":"S Rausch","year":"2022","unstructured":"Rausch S, Foller M (2022) The regulation of FGF23 under physiological and pathophysiological conditions. Pflugers Arch 474:281\u2013292","journal-title":"Pflugers Arch"},{"key":"6395_CR50","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1210\/en.2005-0777","volume":"146","author":"F Perwad","year":"2005","unstructured":"Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146:5358\u20135364","journal-title":"Endocrinology"},{"key":"6395_CR51","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N (2005) Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543\u20132549","journal-title":"J Biol Chem"},{"key":"6395_CR52","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bone.2005.03.002","volume":"36","author":"X Yu","year":"2005","unstructured":"Yu X, Sabbagh Y, Davis SI, Demay MB, White KE (2005) Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone 36:971\u2013977","journal-title":"Bone"},{"key":"6395_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmet.2018.02.007","volume":"11","author":"N Bon","year":"2018","unstructured":"Bon N, Frangi G, Sourice S, Guicheux J, Beck-Cormier S, Beck L (2018) Phosphate-dependent FGF23 secretion is modulated by PiT2\/Slc20a2. Mol Metab 11:197\u2013204","journal-title":"Mol Metab"},{"key":"6395_CR54","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1073\/pnas.1815166116","volume":"116","author":"Y Takashi","year":"2019","unstructured":"Takashi Y, Kosako H, Sawatsubashi S, Kinoshita Y, Ito N, Tsoumpra MK, Nangaku M, Abe M, Matsuhisa M, Kato S, Matsumoto T, Fukumoto S (2019) Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation. Proc Natl Acad Sci U S A 116:11418\u201311427","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6395_CR55","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1172\/JCI131190","volume":"130","author":"P Simic","year":"2020","unstructured":"Simic P, Kim W, Zhou W, Pierce KA, Chang W, Sykes DB, Aziz NB, Elmariah S, Ngo D, Pajevic PD, Govea N, Kestenbaum BR, de Boer IH, Cheng Z, Christov M, Chun J, Leaf DE, Waikar SS, Tager AM, Gerszten RE, Thadhani RI, Clish CB, Juppner H, Wein MN, Rhee EP (2020) Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney. J Clin Invest 130:1513\u20131526","journal-title":"J Clin Invest"},{"key":"6395_CR56","doi-asserted-by":"publisher","first-page":"e164610","DOI":"10.1172\/JCI164610","volume":"133","author":"W Zhou","year":"2023","unstructured":"Zhou W, Simic P, Zhou IY, Caravan P, Vela Parada X, Wen D, Washington OL, Shvedova M, Pierce KA, Clish CB, Mannstadt M, Kobayashi T, Wein MN, Juppner H, Rhee EP (2023) Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis. J Clin Invest 133:e164610","journal-title":"J Clin Invest"},{"key":"6395_CR57","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305\u20131315","journal-title":"J Am Soc Nephrol"},{"key":"6395_CR58","doi-asserted-by":"publisher","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","volume":"288","author":"M Ito","year":"2005","unstructured":"Ito M, Sakai Y, Furumoto M, Segawa H, Haito S, Yamanaka S, Nakamura R, Kuwahata M, Miyamoto K (2005) Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am J Physiol Endocrinol Metab 288:E1101\u2013E1109","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6395_CR59","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1681\/ASN.2011101006","volume":"23","author":"ME Rodriguez-Ortiz","year":"2012","unstructured":"Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR, Martinez-Moreno JM, Ramirez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190\u20131197","journal-title":"J Am Soc Nephrol"},{"key":"6395_CR60","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.kint.2019.10.019","volume":"97","author":"KI Akiyama","year":"2020","unstructured":"Akiyama KI, Miura Y, Hayashi H, Sakata A, Matsumura Y, Kojima M, Tsuchiya K, Nitta K, Shiizaki K, Kurosu H, Kuro OM (2020) Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts. Kidney Int 97:702\u2013712","journal-title":"Kidney Int"},{"key":"6395_CR61","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1210\/en.2013-1627","volume":"154","author":"V David","year":"2013","unstructured":"David V, Dai B, Martin A, Huang J, Han X, Quarles LD (2013) Calcium regulates FGF-23 expression in bone. Endocrinology 154:4469\u20134482","journal-title":"Endocrinology"},{"key":"6395_CR62","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1210\/en.2016-1451","volume":"158","author":"VM Knab","year":"2017","unstructured":"Knab VM, Corbin B, Andrukhova O, Hum JM, Ni P, Rabadi S, Maeda A, White KE, Erben RG, Juppner H, Christov M (2017) Acute parathyroid hormone injection increases C-terminal but not intact fibroblast growth factor 23 levels. Endocrinology 158:1130\u20131139","journal-title":"Endocrinology"},{"key":"6395_CR63","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","volume":"49","author":"Y Rhee","year":"2011","unstructured":"Rhee Y, Bivi N, Farrow E, Lezcano V, Plotkin LI, White KE, Bellido T (2011) Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 49:636\u2013643","journal-title":"Bone"},{"key":"6395_CR64","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1359\/jbmr.090406","volume":"24","author":"SM Burnett-Bowie","year":"2009","unstructured":"Burnett-Bowie SM, Henao MP, Dere ME, Lee H, Leder BZ (2009) Effects of hPTH(1\u201334) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men. J Bone Miner Res 24:1681\u20131685","journal-title":"J Bone Miner Res"},{"key":"6395_CR65","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1681\/ASN.2006070783","volume":"18","author":"T Kawata","year":"2007","unstructured":"Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y (2007) Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 18:2683\u20132688","journal-title":"J Am Soc Nephrol"},{"key":"6395_CR66","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro O, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003\u20134008","journal-title":"J Clin Invest"},{"key":"6395_CR67","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.kint.2017.02.014","volume":"92","author":"H Komaba","year":"2017","unstructured":"Komaba H, Kaludjerovic J, Hu DZ, Nagano K, Amano K, Ide N, Sato T, Densmore MJ, Hanai JI, Olauson H, Bellido T, Larsson TE, Baron R, Lanske B (2017) Klotho expression in osteocytes regulates bone metabolism and controls bone formation. Kidney Int 92:599\u2013611","journal-title":"Kidney Int"},{"key":"6395_CR68","doi-asserted-by":"publisher","first-page":"F785","DOI":"10.1152\/ajprenal.00250.2021","volume":"321","author":"CJ Kung","year":"2021","unstructured":"Kung CJ, Haykir B, Schnitzbauer U, Egli-Spichtig D, Hernando N, Wagner CA (2021) Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo. Am J Physiol Renal Physiol 321:F785\u2013F798","journal-title":"Am J Physiol Renal Physiol"},{"key":"6395_CR69","doi-asserted-by":"publisher","first-page":"F351","DOI":"10.1152\/ajprenal.00232.2013","volume":"306","author":"J Gattineni","year":"2014","unstructured":"Gattineni J, Alphonse P, Zhang Q, Mathews N, Bates CM, Baum M (2014) Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. Am J Physiol Renal Physiol 306:F351-358","journal-title":"Am J Physiol Renal Physiol"},{"key":"6395_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421\u2013432","journal-title":"Matrix Biol"},{"key":"6395_CR71","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1210\/en.2003-1768","volume":"145","author":"T Larsson","year":"2004","unstructured":"Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H, Jonsson KB (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145:3087\u20133094","journal-title":"Endocrinology"},{"key":"6395_CR72","doi-asserted-by":"publisher","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","volume":"297","author":"J Gattineni","year":"2009","unstructured":"Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M (2009) FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297:F282\u2013F291","journal-title":"Am J Physiol Renal Physiol"},{"key":"6395_CR73","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1681\/ASN.2007121301","volume":"19","author":"S Liu","year":"2008","unstructured":"Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD (2008) FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 19:2342\u20132350","journal-title":"J Am Soc Nephrol"},{"key":"6395_CR74","doi-asserted-by":"publisher","first-page":"F769","DOI":"10.1152\/ajprenal.00248.2006","volume":"292","author":"H Segawa","year":"2007","unstructured":"Segawa H, Yamanaka S, Ohno Y, Onitsuka A, Shiozawa K, Aranami F, Furutani J, Tomoe Y, Ito M, Kuwahata M, Imura A, Nabeshima Y, Miyamoto K (2007) Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 292:F769-779","journal-title":"Am J Physiol Renal Physiol"},{"key":"6395_CR75","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1096\/fj.08-114397","volume":"23","author":"T Nakatani","year":"2009","unstructured":"Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS (2009) In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J 23:433\u2013441","journal-title":"FASEB J"},{"key":"6395_CR76","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1096\/fj.10-154765","volume":"24","author":"MC Hu","year":"2010","unstructured":"Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24:3438\u20133450","journal-title":"FASEB J"},{"key":"6395_CR77","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","volume":"51","author":"O Andrukhova","year":"2012","unstructured":"Andrukhova O, Zeitz U, Goetz R, Mohammadi M, Lanske B, Erben RG (2012) FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway. Bone 51:621\u2013628","journal-title":"Bone"},{"key":"6395_CR78","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/jbmr.401","volume":"26","author":"D Ranch","year":"2011","unstructured":"Ranch D, Zhang MY, Portale AA, Perwad F (2011) Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice. J Bone Miner Res 26:1883\u20131890","journal-title":"J Bone Miner Res"},{"key":"6395_CR79","doi-asserted-by":"publisher","first-page":"e0142924","DOI":"10.1371\/journal.pone.0142924","volume":"10","author":"AA Portale","year":"2015","unstructured":"Portale AA, Zhang MY, David V, Martin A, Jiao Y, Gu W, Perwad F (2015) Characterization of FGF23-dependent Egr-1 cistrome in the mouse renal proximal tubule. PLoS ONE 10:e0142924","journal-title":"PLoS ONE"},{"key":"6395_CR80","doi-asserted-by":"publisher","first-page":"E508","DOI":"10.1152\/ajpendo.00499.2010","volume":"300","author":"H Li","year":"2011","unstructured":"Li H, Martin A, David V, Quarles LD (2011) Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype. Am J Physiol Endocrinol Metab 300:E508\u2013E517","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6395_CR81","doi-asserted-by":"publisher","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","volume":"301","author":"J Gattineni","year":"2011","unstructured":"Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M (2011) Regulation of serum 1,25 (OH) 2 Vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol 301:F371\u2013F377","journal-title":"Am J Physiol Renal Physiol"},{"key":"6395_CR82","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","volume":"18","author":"Y Sabbagh","year":"2011","unstructured":"Sabbagh Y, Giral H, Caldas Y, Levi M, Schiavi SC (2011) Intestinal phosphate transport. Adv Chronic Kidney Dis 18:85\u201390","journal-title":"Adv Chronic Kidney Dis"},{"key":"6395_CR83","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","volume":"9","author":"K Miyamoto","year":"2005","unstructured":"Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H (2005) Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 9:331\u2013335","journal-title":"Ther Apher Dial"},{"key":"6395_CR84","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1507\/endocrj.EJ22-0239","volume":"69","author":"T Michigami","year":"2022","unstructured":"Michigami T (2022) Advances in understanding of phosphate homeostasis and related disorders. Endocr J 69:881\u2013896","journal-title":"Endocr J"},{"key":"6395_CR85","unstructured":"Carpenter TO (2022) Primary disorders of phosphate metabolism. In: Feingold KR, Anawalt B, Blackman MR et al (eds) Endotext [Internet]. South Dartmouth\u00a0(MA): MDText.com, Inc.; 2000. Available from:\nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279172\/"},{"key":"6395_CR86","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00005792-199105000-00006","volume":"70","author":"RW Winters","year":"1991","unstructured":"Winters RW, Graham JB, Williams TF, McFalls VW, Burnett CH (1991) A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature. 1958. Medicine (Baltimore) 70:215\u2013217","journal-title":"Medicine (Baltimore)"},{"key":"6395_CR87","doi-asserted-by":"crossref","unstructured":"(1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet 11:130\u2013136","DOI":"10.1038\/ng1095-130"},{"key":"6395_CR88","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte MP, Carpenter TO, Gottesman GS, Mao M, Skrinar A, San Martin J, Imel EA (2019) Efficacy and safety of burosumab in children aged 1\u20134 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial. Lancet Diabetes Endocrinol 7:189\u2013199","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6395_CR89","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Hogler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393:2416\u20132427","journal-title":"Lancet"},{"key":"6395_CR90","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","volume":"303","author":"FH Glorieux","year":"1980","unstructured":"Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023\u20131031","journal-title":"N Engl J Med"},{"key":"6395_CR91","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/jc.2009-1671","volume":"95","author":"EA Imel","year":"2010","unstructured":"Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95:1846\u20131850","journal-title":"J Clin Endocrinol Metab"},{"key":"6395_CR92","first-page":"287","volume":"7","author":"JW Bianchine","year":"1971","unstructured":"Bianchine JW, Stambler AA, Harrison HE (1971) Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser 7:287\u2013295","journal-title":"Birth Defects Orig Artic Ser"},{"key":"6395_CR93","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1210\/jc.2011-1239","volume":"96","author":"EA Imel","year":"2011","unstructured":"Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ (2011) Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab 96:3541\u20133549","journal-title":"J Clin Endocrinol Metab"},{"key":"6395_CR94","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/clinem\/dgac433","volume":"107","author":"X Bai","year":"2022","unstructured":"Bai X, Levental M, Karaplis AC (2022) Burosumab treatment for autosomal recessive hypophosphatemic rickets type 1 (ARHR1). J Clin Endocrinol Metab 107:2777\u20132783","journal-title":"J Clin Endocrinol Metab"},{"key":"6395_CR95","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1038\/s41436-021-01228-4","volume":"23","author":"R Stern","year":"2021","unstructured":"Stern R, Levi DS, Gales B, Rutsch F, Salusky IB (2021) Correspondence on \u201cProspective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)\u201d by Ferreira et al. Genet Med 23:2006\u20132007","journal-title":"Genet Med"},{"key":"6395_CR96","unstructured":"McCune DJ (1936)\u00a0Osteitis fibrosa cystica: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52:743\u2013744"},{"key":"6395_CR97","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1359\/jbmr.2001.16.5.806","volume":"16","author":"MT Collins","year":"2001","unstructured":"Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG (2001) Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16:806\u2013813","journal-title":"J Bone Miner Res"},{"key":"6395_CR98","unstructured":"Ramnitz MS, Gafni RI, Collins MT (2018) Hyperphosphatemic familial tumoral calcinosis. In: Adam MP,\u00a0Feldman J, Mirzaa GM, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle, pp 1993\u20132024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK476672\/"},{"key":"6395_CR99","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36:579\u2013581","journal-title":"Nat Genet"},{"key":"6395_CR100","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1210\/jc.2005-0301","volume":"90","author":"K Araya","year":"2005","unstructured":"Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita T, Silver J, Igarashi T, Fujita T (2005) A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 90:5523\u20135527","journal-title":"J Clin Endocrinol Metab"},{"key":"6395_CR101","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pages","year":"2005","unstructured":"Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385\u2013390","journal-title":"Hum Mol Genet"},{"key":"6395_CR102","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117:2684\u20132691","journal-title":"J Clin Invest"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06395-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06395-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T12:03:48Z","timestamp":1729857828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06395-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":102,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6395"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06395-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}